search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection prevention


objective evidence delivered in real time. This aligns closely with the direction of travel outlined in the NHS’s 10 Year Health Plan. The shift from hospital to community, from analogue to digital, and from sickness to prevention has become a well-established strategic ambition. Yet what the panel made clear is that these ambitions cannot be realised at scale without diagnostics being embedded at the centre of care pathways. The transition towards more preventative,


proactive and community-focused models of care depend on clinicians having access to timely information wherever patients present. Diagnostics provide that foundation. They help identify risk earlier, enable faster intervention, support more personalised care decisions and create opportunities to manage patients within community settings when appropriate. In many respects, diagnostics act as the enabler of wider transformation. Testing at the right point within a pathway


changes what is possible. It can support earlier triage in primary and community care settings, facilitate more informed decision-making in urgent treatment centres and emergency departments, and help ensure patients are treated promptly in the most appropriate environment. This has implications not only for individual patient outcomes but also for the sustainability of healthcare services more broadly. As pressure continues to grow across urgent


Scaling diagnostics safely requires trust: trust in the results, trust in the technology, trust in the governance processes behind them and trust in the systems that enable their effective use.


and emergency care, reducing avoidable demand on acute hospitals remains a priority. Diagnostics have an important role to play in achieving this. By providing timely clarity earlier in the patient journey, they can reduce unnecessary admissions, support safe discharge decisions and help ensure that secondary care capacity is reserved for those who need it most. The examples discussed during the session demonstrated that this opportunity is already being realised in practice. Respiratory pathways, C-reactive protein (CRP) testing in community and virtual ward settings, and urinary tract infection diagnostics all illustrated how integrating testing into care pathways can enable same-episode decisions, reduce delays and support more targeted treatment approaches. These examples also highlighted a broader


principle. Effective diagnostic transformation is not about introducing a new technology in isolation. It is about redesigning pathways around the information that diagnostics can provide. The greatest benefits are achieved when


testing is integrated into clinical workflows, supported by governance structures, connected


to digital systems and aligned with clear patient outcomes. Yet if the opportunity is increasingly clear, so too are the barriers that remain. As previously established, the challenge


facing the NHS is not whether point-of-care diagnostics work. Rather, it is whether the system is configured to adopt and scale them consistently. Questions surrounding governance, accountability, workforce capability, procurement models and interoperability continue to limit the pace of adoption. As several themes echoed throughout the discussion, access alone is not transformation. Delivering a diagnostic device into a care setting does not automatically deliver better outcomes. Success depends on the wider ecosystem surrounding it. Scaling diagnostics safely requires trust: trust


in the results, trust in the technology, trust in the governance processes behind them and trust in the systems that enable their effective use. That trust is built through robust quality frameworks, clear accountability structures and strong collaboration between laboratories and frontline clinical teams. Far from being an obstacle, governance becomes the foundation upon which confident clinical adoption can be achieved. The discussion also highlighted the evolving


role of pathology and laboratory services. Laboratories are increasingly being asked to act not simply as providers of testing, but as strategic partners enabling wider healthcare transformation. This includes supporting quality assurance, providing education and training, overseeing governance and helping ensure that


58 www.clinicalservicesjournal.com I September 2026


Fahroni - stock.adobe.com


Graphicroyalty - stock.adobe.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85